By proceeding, you agree to our Terms of Use and Privacy Policy.
Pheon Therapeutics is leveraging two decades of ADC experience to build a novel pipeline of next generation ADCs which offer the potential to treat solid tumors and liquid cancers that do not respond to other treatments.
13-16 March 2023
The 13th Annual World ADC London returns in 2023 as Europe’s longest standing and definitive antibody-drug conjugate event - and it’s back bigger and better than before! With the recent approval of Astrazeneca and Daiichi Sankyo’s DESTINY-Breast04, s
Event Ended
UK
Paid
London